InvestorsHub Logo
Followers 1
Posts 27
Boards Moderated 0
Alias Born 02/06/2013

Re: isaeed post# 19874

Thursday, 10/31/2013 8:45:12 AM

Thursday, October 31, 2013 8:45:12 AM

Post# of 424639
AMRN will not just withdraw Anchor and cancel Reduce-It - at the present time those are the keys to unlocking the value in Vascepa though I suspect there will be more indications in the future (such as numerous inflammatory diseases). IMHO we are sitting on a blockbuster that is completely unrecognized by the FDA and the markets. Let's remember the markets are not infallible and neither is the FDA.

Please also keep in mind that the people at AMRN have the most to gain from success with Anchor and Reduce-It. I would be willing to wager a case of Jamiesons that many if not all of the employees left are sitting on out of the money stock grants that they'd love to exercise.

This stock is going to require a steel stomach but I still believe AMRN will prevail in the end. That and a buck won't buy you a cup of coffee but its my story and I'm sticking to it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News